Maito, Nasheed A.
HRN: 27-59-19 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/03/2025
08/10/2025
IV
21mg
Q24hours
Neonatal Sepsis
Checking Initial Appropriateness
08/03/2025
AMPICILLIN 250MG (VIAL)
08/03/2025
08/10/2025
IV
70mg
Q12hours
Neonatal Sepsis
Checking Initial Appropriateness
03/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/06/2026
03/13/2026
IV DRIP
250mg
Q6
PCAP-C
Checking Initial Appropriateness
03/06/2026
CEFTRIAXONE 1G (VIAL)
03/06/2026
03/12/2026
IV DRIP
450mg
Q24
PCAP-C
Checking Initial Appropriateness